Insider Shareholders with Direct Ownership of Epizyme, Inc. (EPZM)
This section provides a comprehensive overview of the insiders with direct ownership of Epizyme, Inc. (EPZM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Epizyme, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Robert B Bazemore
President & CEO |
87,500 | 20,287 | 322,626 $0 | 4 |
Mar 25, 2021
Reduced 3.1%
|
|
Matthew Ros
Officer |
56,250 | 3,766 | 111,313 $0 | 4 |
Aug 16, 2021
Added 20.17%
|
|
Paolo Tombesi
Chief Financial Officer |
26,041 | 1,021 | 53,465 $0 | 2 |
Feb 04, 2021
Reduced 1.87%
|
|
Victoria Vakiener
Chief Commercial Officer |
25,520 | 1,416 | 52,685 $0 | 3 |
Feb 04, 2021
Reduced 1.53%
|
|
Andrew R Allen
Director |
8,060 | 0 | 20,560 $0 | 1 |
Jun 11, 2021
Added 28.16%
|
|
Beveridge, Roy A
Director |
46,037 | 46,037 | 0 $0 | 5 |
Aug 12, 2022
Reduced 100.0%
|
|
Carol Stuckley
Director |
25,696 | 25,696 | 0 $0 | 3 |
Aug 12, 2022
Reduced 100.0%
|
|
Kevin T Conroy
Director |
54,716 | 62,318 | 0 $0 | 11 |
Aug 12, 2022
Reduced 100.0%
|
|
David M Mott
Director |
140,428 | 224,488 | 0 $0 | 13 |
Aug 12, 2022
Reduced 100.0%
|
| 591,080 | 674,455 | 0 $0 | 13 |
Aug 12, 2022
Reduced 100.0%
|
|
|
Joseph Beaulieu
Officer |
324,864 | 333,076 | 0 $0 | 9 |
Aug 12, 2022
Reduced 100.0%
|
|
Grant C. Bogle
President and CEO |
1,400,560 | 1,400,560 | 0 $0 | 6 |
Aug 12, 2022
Reduced 100.0%
|
|
Jeffery Kutok
Chief Scientific Officer |
454,477 | 481,889 | 0 $0 | 8 |
Aug 12, 2022
Reduced 100.0%
|
|
Kenneth Bate
Director |
17,054 | 17,054 | 0 $0 | 3 |
Aug 12, 2022
Reduced 100.0%
|
|
Victoria Richon
Director |
17,054 | 22,608 | 0 $0 | 3 |
Aug 12, 2022
Reduced 100.0%
|
|
Carl Goldfischer
Director |
22,054 | 22,054 | 0 $0 | 4 |
Aug 12, 2022
Reduced 100.0%
|
|
Michael F Giordano
Director |
17,054 | 17,054 | 0 $0 | 3 |
Aug 12, 2022
Reduced 100.0%
|